PIAS1 is a crucial factor for prostate cancer cell survival and a valid target in docetaxel resistant cells

Occurrence of an inherent or acquired resistance to the chemotherapeutic drug docetaxel is a major burden for patients suffering from different kinds of malignancies, including castration resistant prostate cancer (PCa). In the present study we address the question whether PIAS1 targeting can be use...

Descripción completa

Detalles Bibliográficos
Autores principales: Puhr, Martin, Hoefer, Julia, Neuwirt, Hannes, Eder, Iris E., Kern, Johann, Schäfer, Georg, Geley, Stephan, Heidegger, Isabel, Klocker, Helmut, Culig, Zoran
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2014
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4322998/
https://www.ncbi.nlm.nih.gov/pubmed/25474038

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4322998/
https://www.ncbi.nlm.nih.gov/pubmed/25474038

Ejemplares similares